Shenzhen S.E.
06:00:00 2024-04-23 pm EDT
5-day change
1st Jan Change
6.72
CNY
+0.30%
+1.97%
+1.36%
Renhe Pharmacy Co., Ltd.'s Equity Buyback announced on July 27, 2021, has expired with 20,380,000 shares, representing 1.46% for CNY 199.64 million.
The company expired its plan on August 9, 2021.
Renhe Pharmacy Gets 58 Million Yuan in Government Grants
Apr. 15
MT
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.
Apr. 01
CI
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.
Jan. 02
CI
Renhe Pharmacy Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.
Dec. 07
CI
Renhe Pharmacy Co., Ltd. authorizes a Buyback Plan.
Dec. 06
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-29
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-24
CI
Renhe Pharmacy Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 08 June 2023
23-06-01
CI
Renhe Pharmacy Co., Ltd. Approves Cash Dividend for 2022
23-05-31
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-27
CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for 2022
23-04-26
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-25
CI
Renhe Pharmacy Gets Nod Tadalafil Tablets' Registration
23-03-06
MT
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-25
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-24
CI
Renhe Pharmacy Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022
22-05-20
CI
Renhe Pharmacy Co., Ltd. Approves Final Cash Dividend for 2021
22-05-19
CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2021
22-04-26
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-26
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-25
CI
Renhe Pharmacy Co., Ltd. Announces Executive Appointments
22-03-22
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
21-10-27
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
21-08-25
CI
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on July 27, 2021.
21-08-10
CI
Renhe Pharmacy Co., Ltd.'s Equity Buyback announced on July 27, 2021, has expired with 20,380,000 shares, representing 1.46% for CNY 199.64 million.
21-08-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
RENHE PHARMACY CO.,LTD is a China-based company principally engaged in pharmaceutical industry. The Company is mainly engaged in medical industrial manufacturing and medical merchandising. The Companyâs main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The Company is also involved in the wholesaling and retailing of health-related products. The Company distributes its products mainly in domestic market.
More about the company
1st Jan change
Capi.
+1.36% 1.29B +25.61% 672B +25.87% 570B -5.24% 360B +16.49% 321B +8.28% 300B +7.09% 217B -9.12% 204B +5.01% 199B -8.75% 149B
Other Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
RENHE PHARMACY CO., LTD. 
